Table 2. % Activity Remaining and IC50 Values of Nilotinib, Ponatinib, 4, and 5 for Selected Kinases.
| % Activity Remaining |
% Activity Remaining and [IC50 (μM)] |
|||
|---|---|---|---|---|
| kinase | Nilotinib | Ponatinib | 4 | 5 |
| ABL | 2 | 1 | 8 [0.0031] | 11 [0.0013] |
| DDR2 | 4 | 3 | 70 [>20] | 14 [0.2862] |
| PDGFRa | 56 | 25 | 10 [0.0021] | 16 [0.0020] |
| Src | 74 | 11 | 23 [0.7097] | 15 [0.4313] |
| EPHB2 | 25 | 2 | 2 [0.0932] | 1 [0.0708] |
| EPHB3 | 52 | 1 | 6 [0.0505] | 5 [0.0195] |
| Lck | 37 | 29 | 22 [0.0908] | 17 [0.0261] |
| EPHA4 | 23 | 4 | 6 [0.1381] | 2 [0.0846] |
| NEK6 | 97 | 52 | 45 [3.3060] | 9 [5.3500] |
| VEGFR | 75 | 28 | 14 [0.0336] | 13 [0.0448] |
| MAP4K3 | 107 | 2 | 62 [>20] | 14 [0.2404] |